Nicholas Edward Tawa, Jr., M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms, Adnexal and Skin Appendage | 1 | 2021 | 27 | 0.730 |
Why?
|
| Sentinel Lymph Node Biopsy | 3 | 2023 | 743 | 0.580 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2930 | 0.420 |
Why?
|
| Parenteral Nutrition, Home Total | 3 | 2002 | 9 | 0.300 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 9425 | 0.250 |
Why?
|
| Catheters, Indwelling | 2 | 2017 | 436 | 0.240 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 5891 | 0.230 |
Why?
|
| Protein Deficiency | 2 | 1992 | 59 | 0.200 |
Why?
|
| Catheterization, Central Venous | 2 | 2017 | 530 | 0.200 |
Why?
|
| Mohs Surgery | 1 | 2021 | 222 | 0.150 |
Why?
|
| Venous Cutdown | 1 | 2017 | 5 | 0.150 |
Why?
|
| Subclavian Vein | 1 | 2017 | 57 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 3 | 2008 | 491 | 0.150 |
Why?
|
| Leupeptins | 1 | 1997 | 113 | 0.140 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 1 | 2017 | 26 | 0.140 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1997 | 189 | 0.140 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2017 | 158 | 0.130 |
Why?
|
| Lymphedema | 1 | 2023 | 527 | 0.130 |
Why?
|
| Lymph Node Excision | 1 | 2021 | 1276 | 0.120 |
Why?
|
| Arm | 1 | 2017 | 590 | 0.120 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 551 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2010 | 1892 | 0.120 |
Why?
|
| Multienzyme Complexes | 1 | 1997 | 666 | 0.110 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2008 | 640 | 0.100 |
Why?
|
| Muscles | 2 | 1992 | 1582 | 0.090 |
Why?
|
| Survival Rate | 3 | 2021 | 12875 | 0.090 |
Why?
|
| Bacteremia | 2 | 2008 | 985 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6537 | 0.090 |
Why?
|
| Malabsorption Syndromes | 1 | 2010 | 135 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 1992 | 618 | 0.080 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 2008 | 26 | 0.080 |
Why?
|
| Phospholipids | 2 | 2010 | 783 | 0.080 |
Why?
|
| Weight Lifting | 1 | 2007 | 130 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2004 | 4984 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 1992 | 1165 | 0.070 |
Why?
|
| Lysosomes | 1 | 1992 | 934 | 0.070 |
Why?
|
| Amino Acids | 1 | 1992 | 1714 | 0.070 |
Why?
|
| Joint Prosthesis | 1 | 2007 | 251 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 1992 | 2003 | 0.060 |
Why?
|
| Melanoma | 2 | 2019 | 5740 | 0.060 |
Why?
|
| Beverages | 1 | 2010 | 822 | 0.060 |
Why?
|
| Carcinoid Tumor | 1 | 2006 | 226 | 0.060 |
Why?
|
| Triglycerides | 2 | 2010 | 2465 | 0.060 |
Why?
|
| Lymph Nodes | 2 | 2023 | 3472 | 0.060 |
Why?
|
| Rats, Inbred Strains | 2 | 1997 | 2087 | 0.060 |
Why?
|
| Arthroplasty, Replacement | 1 | 2006 | 310 | 0.050 |
Why?
|
| Cachexia | 1 | 2004 | 202 | 0.050 |
Why?
|
| Hip Prosthesis | 1 | 2008 | 924 | 0.050 |
Why?
|
| Proteins | 1 | 1997 | 6008 | 0.050 |
Why?
|
| Fatty Acids, Essential | 1 | 2002 | 97 | 0.050 |
Why?
|
| Hip Joint | 1 | 2008 | 1018 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2004 | 335 | 0.050 |
Why?
|
| Short Bowel Syndrome | 2 | 2002 | 353 | 0.050 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2010 | 1398 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2007 | 1185 | 0.040 |
Why?
|
| Aged | 11 | 2021 | 171520 | 0.040 |
Why?
|
| Enteritis | 1 | 2001 | 164 | 0.040 |
Why?
|
| Urinary Tract Infections | 1 | 2006 | 806 | 0.040 |
Why?
|
| Middle Aged | 13 | 2021 | 223418 | 0.040 |
Why?
|
| Male | 18 | 2021 | 364781 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 21156 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 24311 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 588 | 0.040 |
Why?
|
| Factor VIII | 1 | 2001 | 349 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2023 | 1998 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2021 | 81834 | 0.040 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 1013 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2007 | 2257 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2008 | 1418 | 0.040 |
Why?
|
| Hemophilia A | 1 | 2001 | 359 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15880 | 0.040 |
Why?
|
| Female | 15 | 2023 | 396943 | 0.040 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2002 | 373 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2007 | 4202 | 0.040 |
Why?
|
| Dietary Proteins | 2 | 1992 | 960 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 2008 | 1937 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2004 | 2491 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 430 | 0.030 |
Why?
|
| Arachidonic Acid | 2 | 2010 | 429 | 0.030 |
Why?
|
| Diaphragm | 1 | 1997 | 360 | 0.030 |
Why?
|
| Decision Trees | 1 | 2017 | 510 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2017 | 916 | 0.030 |
Why?
|
| Humans | 20 | 2023 | 768451 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13708 | 0.030 |
Why?
|
| Organ Size | 2 | 2004 | 2268 | 0.030 |
Why?
|
| Rats | 3 | 1997 | 23839 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 11249 | 0.030 |
Why?
|
| Atrophy | 1 | 1997 | 1648 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2001 | 3234 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1997 | 1322 | 0.020 |
Why?
|
| Growth | 1 | 1992 | 366 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 4362 | 0.020 |
Why?
|
| Alanine | 1 | 1992 | 613 | 0.020 |
Why?
|
| Kinetics | 1 | 1997 | 6348 | 0.020 |
Why?
|
| Glutamine | 1 | 1992 | 578 | 0.020 |
Why?
|
| Time Factors | 3 | 2002 | 40271 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4931 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 22386 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 2007 | 318 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2010 | 663 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 2007 | 270 | 0.020 |
Why?
|
| Anabolic Agents | 1 | 2007 | 256 | 0.020 |
Why?
|
| Adult | 8 | 2019 | 223542 | 0.020 |
Why?
|
| Salicylates | 1 | 2004 | 128 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2001 | 22293 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 250 | 0.010 |
Why?
|
| Steroids | 1 | 2007 | 937 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13324 | 0.010 |
Why?
|
| Hindlimb | 1 | 2004 | 516 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39430 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2008 | 1599 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2007 | 1095 | 0.010 |
Why?
|
| Linoleic Acid | 1 | 2002 | 159 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 952 | 0.010 |
Why?
|
| Cytokines | 2 | 2008 | 7449 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1629 | 0.010 |
Why?
|
| Mastectomy, Segmental | 1 | 2006 | 961 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 1794 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 2017 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4586 | 0.010 |
Why?
|
| Omentum | 1 | 2001 | 168 | 0.010 |
Why?
|
| Animals | 4 | 2004 | 169418 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2004 | 843 | 0.010 |
Why?
|
| Calcium | 1 | 1992 | 5793 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2568 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 3594 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2002 | 633 | 0.010 |
Why?
|
| Clone Cells | 1 | 2001 | 1672 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2006 | 3550 | 0.010 |
Why?
|
| Radiography | 1 | 2008 | 6995 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2010 | 3445 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 59680 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4029 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2228 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 8730 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5495 | 0.010 |
Why?
|
| Heart Arrest | 1 | 1967 | 1516 | 0.010 |
Why?
|
| Sarcoma | 1 | 2007 | 1806 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65409 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2001 | 2126 | 0.010 |
Why?
|
| Heart Rate | 1 | 2007 | 4218 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2269 | 0.010 |
Why?
|
| Mammography | 1 | 2006 | 2436 | 0.010 |
Why?
|
| Child | 1 | 2023 | 80863 | 0.010 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2002 | 1126 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2002 | 1818 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8559 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3734 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 4630 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2002 | 1207 | 0.010 |
Why?
|
| Iron | 1 | 2002 | 1813 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 5767 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 60045 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2007 | 8538 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9558 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 89168 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8635 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7895 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 4180 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 15609 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 74915 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2001 | 2056 | 0.010 |
Why?
|
| Biopsy | 1 | 2001 | 6816 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2001 | 3458 | 0.000 |
Why?
|
| Skin | 1 | 2001 | 4520 | 0.000 |
Why?
|
| Liver | 1 | 2002 | 7575 | 0.000 |
Why?
|
| Phenotype | 1 | 2004 | 16712 | 0.000 |
Why?
|
| Death, Sudden | 1 | 1967 | 301 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20762 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2004 | 23638 | 0.000 |
Why?
|
| Brain | 1 | 1967 | 27438 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 82045 | 0.000 |
Why?
|